Separation Agreement and General Release of Claims (March 6th, 2017)
THIS SEPARATION AGREEMENT AND GENERAL RELEASE OF CLAIMS (hereinafter "Agreement") is entered into by and between Gregory D. Gorgas (hereinafter "Employee") and Mast Therapeutics, Inc. (hereinafter "Mast"). Employee and Mast hereinafter are collectively referred to as "the Parties."
Executive Severance Agreement (May 6th, 2016)
This Executive Severance Agreement ("Agreement") is dated March 23, 2016 ("Effective Date"), and is between Gregory D. Gorgas ("Executive") and Mast Therapeutics, Inc., a Delaware corporation ("Company"). Each of the Company and Executive are a "Party" and, collectively, they are the "Parties." Any capitalized but undefined term in this Agreement shall have the meaning assigned to it in Section 3 of this Agreement.
Adventrx Pharmaceuticals, Inc. Change in Control Severance Plan (December 7th, 2012)
This document sets forth all applicable terms of the Change in Control Severance Plan (this Plan) of ADVENTRX Pharmaceuticals, Inc., a Delaware corporation (the Company), effective as of the date set forth above and until further amended or terminated by the Companys Board of Directors or a properly authorized committee thereof (collectively, the Board) in accordance with Section 12(a). Certain capitalized terms used in this Plan are defined in Section 11.